申请人:NEKTAR THERAPEUTICS
公开号:WO2012088529A1
公开(公告)日:2012-06-28
The invention relates to (among other things) polymer-sunitinib conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over sunitinib in unconjugated form.